Evidence map›Paper›PMID 19294772›Full record

ArticleWorld journal of gastroenterology2009

Resected case of eosinophilic cholangiopathy presenting with secondary sclerosing cholangitis.

Fumihiko Miura, Takehide Asano, Hodaka Amano, Masahiro Yoshida, Naoyuki Toyota, Keita Wada, Kenichiro Kato, Tadahiro Takada, Junichi Fukushima, Fukuo Kondo and 1 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in World journal of gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Eosinophilic cholangitis and cholangiopathy: a sheep in wolves clothing.HPB surgery : a world journal of hepatic, pancreatic and biliary surgery · 2010
    Review
  15. A rare case of eosinophilic cholangiopathy.International journal of immunopathology and pharmacology
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Fumihiko MiuraDepartment of Surgery, Teikyo University, School of Medicine, Tokyo, 173-8605, Japan.
Takehide Asano
Hodaka Amano
Masahiro Yoshida
Naoyuki Toyota
Keita Wada
Kenichiro Kato
Tadahiro Takada
Junichi Fukushima
Fukuo Kondo
Hajime Takikawa
Teikyo University · JPVanderbilt University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eosinophilic cholangiopathy is a rare condition characterized by eosinophilic infiltration of the biliary tract and causes sclerosing cholangitis. We report a patient with secondary sclerosing cholangitis with eosinophilic cholecystitis. A 46-year-old Japanese man was admitted to our hospital with jaundice. Computed tomography revealed dilatation of both the intrahepatic and extrahepatic bile ducts, diffuse thickening of the wall of the extrahepatic bile duct, and thickening of the gallbladder wall. Under the diagnosis of lower bile duct carcinoma, he underwent pylorus-preserving pancreatoduodenectomy and liver biopsy. On histopathological examination, conspicuous fibrosis was seen in the lower bile duct wall. In the gallbladder wall, marked eosinophilic infiltration was seen. Liver biopsy revealed mild portal fibrosis. He was diagnosed as definite eosinophilic cholecystitis with sclerosing cholangitis with unknown etiology. The possible etiology of sclerosing cholangitis was consequent fibrosis from previous eosinophilic infiltration in the bile duct. The clinicopathological findings of our case and a literature review indicated that eosinophilic cholangiopathy could cause a condition mimicking primary sclerosing cholangitis (PSC). Bile duct wall thickening in patients with eosinophilic cholangitis might be due to fibrosis of the bile duct wall. Eosinophilic cholangiopathy might be confused as PSC with eosinophilia.

Indexed as

Bile Duct NeoplasmsBile Ducts, ExtrahepaticBile Ducts, IntrahepaticCholangitisCholangitis, SclerosingDiagnosis, DifferentialHumansJaundiceMaleMiddle AgedRadiographyTreatment Outcome

Identifiers

PMID19294772
PMCPMC2658845
OpenAlexW2162205676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.